Covid-19 research: Inhaled multiple sclerosis drug 'speeds recovery'

0
6

Just 13 per cent of Covid-19 hospital patients given SNG001 fell ill enough to need intensive care, compared to 22 per cent of those on a placebo, the Southampton University study found.
Source: www.dailymail.co.uk